A dual agonist of the CB1 and CB2 receptors
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

CB-13

Item No. 10010398

Technical Information
Formal Name
1-naphthalenyl[4-(pentylox)-1-naphthalenyl]-methanone
CAS Number
432047-72-8
Synonyms
  • CRA-13
Molecular Formula
C26H24O2
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 20 mg/mlDMSO: 5 mg/mlEthanol: 0.2 mg/mlMethanol: 1 mg/ml
λmax
220, 333 nm
SMILES
CCCCCOc1ccc(c2ccccc12)C(=O)c1cccc2ccccc12
InChi Code
InChI=1S/C26H24O2/c1-2-3-8-18-28-25-17-16-24(21-13-6-7-14-22(21)25)26(27)23-15-9-11-19-10-4-5-12-20(19)23/h4-7,9-17H,2-3,8,18H2,1H3
InChi Key
RSUMDJRTAFBISX-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cannabinoid Resource Center
    Discover Our Tools to Support Cannabinoid Research and Analysis.
    • Cannabinoid signaling research products
    • Analytical standards and certified reference materials
    • Endocannabinoid profiling services
    • Lab wall posters
    • Articles, application notes, and webinars
    LEARN MORE
    Product Description

    CB-13 is a dual agonist of the CB1 (IC50 = 15 nM) and CB2 (IC50 = 98 nM) receptors.1 In rats, oral CB-13 (3 mg/kg) potently blocks CB1-dependent neuropathic mechanical hyperalgesia, shows limited brain penetration, and exhibits good oral bioavailability.1 CB-13 does not possess genotoxic potential, as indicated by negative results in both chromosome aberration and reverse mutation assays.1 The effects of CB-13 on other aspects of CB signaling have not been assessed.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Dziadulewicz, E.K., Bevan, S.J., Brain, C.T., et alNaphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: A potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration. J. Med. Chem. 50(16), 3851-3856 (2007).